MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 69 filers reported holding MEI PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $589,852 | -6.0% | 2,576,900 | 0.0% | 0.00% | +33.3% |
| Q4 2022 | $627,733 | -37.0% | 2,576,900 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $996,000 | -36.1% | 2,576,900 | 0.0% | 0.01% | -75.0% |
| Q2 2022 | $1,559,000 | +323.6% | 2,576,900 | +2047.6% | 0.02% | +380.0% |
| Q1 2019 | $368,000 | +332.9% | 119,990 | +272.9% | 0.01% | +150.0% |
| Q4 2018 | $85,000 | – | 32,178 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |